Post by
prophetoffactz on Apr 18, 2023 3:20pm
J&J released earnings today:
"Consumer Health
Consumer Health worldwide adjusted operational sales increased 11.3%* largely driven by over-the-counter (OTC) products. Major contributors to growth in OTC were TYLENOL and MOTRIN analgesics, upper respiratory products, IMODIUM in digestive health products and international smoking cessation products. Additional contributors to growth were NEUTROGENA and AVEENO in Skin Health/Beauty products and JOHNSON’s in Baby Care products."
Comment by
prophetoffactz on Apr 18, 2023 3:26pm
J&J reports in US dollars and the US dollar is generally stronger year-over-year. With the Canadain dollar down significantly year-over-year and CZO reporting in Canadian dollars CZO will have a boost in revenue that J&J didn't due to currency.
Comment by
Hopeforthebest on Apr 18, 2023 4:22pm
So what you are saying is that if the US was lower in value q3 and q4 results would have been even worse
Comment by
PBaelishh on Apr 18, 2023 4:39pm
GREAT QUESTION! No QUANT, just... a dump of QUALITATIVE facts excerpted from a press release... remind you of anyone?